Tevogen Q3: $144,713 Cash, Missed Payroll, $28.6M Related-Party Lifeline
TVGN sits 71% above its 52-week low of $3.636 on light trading volume (0.4× avg).
Summary
Tevogen reported a $7.0 million Q3 loss with only $144,713 of cash, disclosed missed payroll payments in October and November, and is leaning on a $28.6 million related-party credit line and a $7.0 million grant commitment to fund the next 12 months.
Key Events · Earnings and Guidance · TVGN
-
Q3 Loss With Near-Zero Cash
Net loss of $7.0 million for the quarter and $18.2 million for nine months, leaving cash of $144,713 at September 30, 2026 versus $552,372 at December 31, 2025.
-
Payroll Missed, Emergency Borrowing
The company did not make two October 2026 and one November 2026 employee payroll payments when due and submitted a notice of borrowing for $850,000 on November 16, 2026 to pay them and associated payroll taxes.
-
Related-Party Loan Amended and Repaid in Stock
The October 27, 2026 amendment raised aggregate post-amendment borrowings to $28.6 million, extended the draw window to May 31, 2029, and set a fixed $7.40 per-share repayment price (down from $75.00); on November 2, 2026 the $7.4 million principal plus $177,880 interest was settled with 1,000,000 Principal Shares and 23,733 Interest Shares.
-
Up to 4.99 Million More Shares
If the full $28.6 million is drawn and repaid in stock at the maximum 7.00% rate, up to approximately 4.99 million additional shares may be issuable, subject to the 9.99% beneficial ownership cap and 19.99% issuance cap.
Analysis · TVGN · Life Sciences
Tevogen closed September with just $144,713 of cash against a $7.0 million quarterly loss, and the filing admits it skipped two October and one November payrolls before borrowing $850,000 on November 16 to catch up. Survival now rests entirely on the Patel Family's amended credit line ($28.6 million available, repayable in stock at a fixed $7.40) and a $7.0 million KRHP grant commitment — both related-party sources. Under the October 27 amendment, the stock repayment price fell from $75.00 to $7.40, meaning future draws convert into far more shares; up to roughly 4.99 million additional shares could be issued if the full facility is drawn and repaid in stock. The company also carries $1.65 million of Polar notes in default since the 2024 merger and repeats a previously disclosed material weakness in internal controls.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TVGN was trading at $6.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.5M. The 52-week trading range was $3.64 to $24.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.